D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 56 Citations 8,911 130 World Ranking 2152 National Ranking 1059

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Immune system
  • Gene

Jonathan S. Serody mainly focuses on Immunology, Graft-versus-host disease, Stem cell, CD8 and Immune system. His Immunology research includes themes of Hematopoietic stem cell transplantation and Transplantation. His Graft-versus-host disease study combines topics in areas such as Recombinant Granulocyte Colony-Stimulating Factor, Cytokine, Granulocyte macrophage colony-stimulating factor, Chemokine and Proinflammatory cytokine.

His work carried out in the field of Stem cell brings together such families of science as Pathology, Cell migration and Effector. His studies deal with areas such as Inflammasome, Adoptive cell transfer, Dendritic cell and Immunity as well as CD8. His Immune system study deals with Cytotoxic T cell intersecting with Cancer research, Immunotherapy and Melanoma.

His most cited work include:

  • Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. (351 citations)
  • L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection (331 citations)
  • In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations (253 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Immunology, Graft-versus-host disease, Transplantation, T cell and Cancer research. His study looks at the relationship between Immunology and topics such as Stem cell, which overlap with Pathology. As a part of the same scientific study, Jonathan S. Serody usually deals with the Graft-versus-host disease, concentrating on Germinal center and frequently concerns with Ibrutinib.

His Transplantation research incorporates elements of Disease and Pathogenesis. His T cell research includes themes of Molecular biology and CD8. In his work, Oncology is strongly intertwined with Breast cancer, which is a subfield of Cancer research.

He most often published in these fields:

  • Immunology (51.17%)
  • Graft-versus-host disease (35.55%)
  • Transplantation (24.61%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (19.14%)
  • T cell (21.48%)
  • Graft-versus-host disease (35.55%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Cancer research, T cell, Graft-versus-host disease, Internal medicine and Immunology. His Cancer research study incorporates themes from Cancer immunotherapy, Immune system, CD19, Immunotherapy and Car t cells. His T cell research is multidisciplinary, incorporating elements of Cell, Priming, CD8 and Cell biology.

Jonathan S. Serody has included themes like Inflammation, Proinflammatory cytokine, Receptor, Dosing and Leukemia in his Graft-versus-host disease study. He interconnects Gastroenterology and Oncology in the investigation of issues within Internal medicine. His study on Immunology is mostly dedicated to connecting different topics, such as Transplantation.

Between 2017 and 2021, his most popular works were:

  • Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma (88 citations)
  • A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy. (67 citations)
  • Alternative tumour-specific antigens. (62 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Gene
  • Immune system

His scientific interests lie mostly in Cancer research, Immunotherapy, T cell, Antigen and Extramural. His Cancer research research integrates issues from Receptor and In vivo. Immune system covers Jonathan S. Serody research in Immunotherapy.

His T cell research incorporates themes from Cell, Priming, CD8 and Cell biology. His work on Receptor expression is being expanded to include thematically relevant topics such as Graft-versus-host disease. His research integrates issues of Mucositis and Myeloid leukemia in his study of Graft-versus-host disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection

Patricia A. Taylor;Angela Panoskaltsis-Mortari;Jessica M. Swedin;Philip J. Lucas.
Blood (2004)

499 Citations

Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.

Steven L. Highfill;Paulo C. Rodriguez;Qing Zhou;Christine A. Goetz.
Blood (2010)

498 Citations

Leukocyte migration and graft-versus-host disease

Christian A. Wysocki;Angela Panoskaltsis-Mortari;Bruce R. Blazar;Jonathan S. Serody.
Blood (2005)

357 Citations

In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

Michael J. Carlson;Michelle L. West;James M. Coghill;Angela Panoskaltsis-Mortari.
Blood (2009)

333 Citations

Intravascular Catheter Exchange and Duration of Candidemia

John H. Rex;John E. Bennett;Alan M. Sugar;Peter G. Pappas.
Clinical Infectious Diseases (1995)

332 Citations

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

Kai Sun;Lisbeth A. Welniak;Angela Panoskaltsis-Mortari;Matthew J. O'Shaughnessy.
Proceedings of the National Academy of Sciences of the United States of America (2004)

299 Citations

Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.

Yuanzeng Min;Kyle C. Roche;Shaomin Tian;Michael J. Eblan.
Nature Nanotechnology (2017)

289 Citations

Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease

Christian A. Wysocki;Qi Jiang;Angela Panoskaltsis-Mortari;Patricia A. Taylor.
Blood (2005)

278 Citations

T-lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease

Jonathan S. Serody;Jonathan S. Serody;Jonathan S. Serody;Susan E. Burkett;Angela Panoskaltsis-Mortari;Angela Panoskaltsis-Mortari;Angela Panoskaltsis-Mortari;Judith Ng-Cashin.
Blood (2000)

190 Citations

Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer

Michael D. Iglesia;Benjamin G. Vincent;Joel S. Parker;Katherine A. Hoadley.
Clinical Cancer Research (2014)

183 Citations

Best Scientists Citing Jonathan S. Serody

Bruce R. Blazar

Bruce R. Blazar

University of Minnesota

Publications: 133

Geoffrey R. Hill

Geoffrey R. Hill

Fred Hutchinson Cancer Research Center

Publications: 65

Chen Liu

Chen Liu

Rutgers, The State University of New Jersey

Publications: 44

Pavan Reddy

Pavan Reddy

University of Michigan–Ann Arbor

Publications: 39

Robert Zeiser

Robert Zeiser

University of Freiburg

Publications: 38

Robert S. Negrin

Robert S. Negrin

Stanford University

Publications: 37

Marcel R.M. van den Brink

Marcel R.M. van den Brink

Memorial Sloan Kettering Cancer Center

Publications: 33

Jerome Ritz

Jerome Ritz

Harvard University

Publications: 32

Corey Cutler

Corey Cutler

Harvard University

Publications: 32

William J. Murphy

William J. Murphy

Texas A&M University

Publications: 31

Gérard Socié

Gérard Socié

Université Paris Cité

Publications: 29

Claudio Anasetti

Claudio Anasetti

Fred Hutchinson Cancer Research Center

Publications: 27

Kelli P. A. MacDonald

Kelli P. A. MacDonald

QIMR Berghofer Medical Research Institute

Publications: 25

Angela Panoskaltsis-Mortari

Angela Panoskaltsis-Mortari

University of Minnesota

Publications: 24

Ernst Holler

Ernst Holler

University of Regensburg

Publications: 24

Joseph H. Antin

Joseph H. Antin

Harvard University

Publications: 23

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.